Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsTo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE Highlights
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Gamma delta (γδ) T cells present the next generation of effector cells for immunotherapy. Unlike alpha beta (αβ) T cell therapies, γδ T cells can be administered off-the-shelf and no need for tailored one for each individual, allowing for scaling up manufacturing process and broader potential use. Accelerating the development of γδ T cell therapies is to deliver the cell therapies of the future. Equipped with rich experience, profound expertise, and state-of-the-art technology, Creative Biolabs has established a cutting-edge γδ T cell platform to provide highly effective off the shelf Vδ1 T cells and Vδ2 T cells with the potential to offer help in the treatment of cancers. We also offer a full range of high-quality services, including γδ T cell isolation, γδ T cell activation, γδ T cell expansion, γδ T cell characterization, and γδ T cell engineering services, to generate Vδ T cell populations suitable for our clients' γδ T cell research and project development. Through our proven quality system, clients could accelerate their research with the most comprehensive view of γδ T cells.
With years of research in γδ T cell development, Creative Biolabs has established a cutting-edge γδ T cell platform for selective isolation, activation, expansion, and characterization of Vδ1 and Vδ2 populations from human tissues and blood. We have developed an economical method to achieve large-scale ex vivo expansion of these γδ T cells. Moreover, our scientists have gained significant knowledge to understand the bioactivity and the activation modalities of γδT cells. We also offer custom γδ T cell engineering services with antibody or cell-based strategies for high efficacy and improved safety. Besides, our R&D scientific team has successfully designed and developed γδ bispecific T-cell engagers, which has demonstrated improved safety and efficacy compared to conventional bispecific T-cell engagers. Creative Biolabs has perfected our technical pipelines in the development of γδ bispecific T-cell engagers. We would like to share our knowledge and passion in this field to facilitate our customers' research and project development.
This subset of γδ T cells plays important roles in mediating innate immunity against a wide variety of infections and displays potent and broad cytotoxic activity against human tumor cells. We believe that future clinical trials would explore the use of γδ T cells or the combinatorial use with other therapeutic agents, such as chimeric antigen receptor (CAR) and immune checkpoint inhibitors. Creative Biolabs strives to constantly improve the quality of the expanded γδ T cells and offer the most comprehensive γδ T cell engineering services. We are proud to provide optional tools to facilitate our clients' research in anti-tumor immunotherapy. For more detailed information, please feel free to contact us or directly send us an inquiry.
References
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
